Filing Details
- Accession Number:
- 0000899243-21-029868
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-07-26 16:05:21
- Reporting Period:
- 2021-07-22
- Accepted Time:
- 2021-07-26 16:05:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1434316 | Fate Therapeutics Inc | FATE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1586893 | Scott J Wolchko | Fate Therapeutics, Inc. 3535 General Atomics Court, Suite 200 San Diego CA 92121 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-07-22 | 30,000 | $2.73 | 423,793 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-22 | 6,627 | $85.38 | 417,166 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-07-22 | 21,773 | $86.19 | 395,393 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-07-22 | 1,600 | $86.90 | 393,793 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-07-23 | 10,000 | $2.73 | 403,793 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-07-23 | 20,000 | $4.84 | 423,793 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-07-23 | 30,000 | $85.28 | 393,793 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-07-22 | 30,000 | $0.00 | 30,000 | $2.73 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-07-23 | 10,000 | $0.00 | 10,000 | $2.73 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-07-23 | 20,000 | $0.00 | 20,000 | $4.84 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 100,000 | 2027-01-03 | No | 4 | M | Direct | |
| 90,000 | 2027-01-03 | No | 4 | M | Direct | |
| 24,846 | 2025-01-04 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2020.
- Represents the weighted average sale price of the shares sold ranging from $84.76 to $85.74 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $85.76 to $86.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- Represents the weighted average sale price of the shares sold ranging from $86.76 to $87.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price.
- This option is fully vested.
Billionaire Hedge Funds
